Researchers from the University of Edinburgh, Scotland, and the University of Cantabria, Spain, have teamed up to develop an AI trained to discover senolytic medicinal chemistry in familiar compounds.
A new automated workflow developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) has the potential to allow researchers to analyze the products of their reaction experiments in real time, a key capability ...
Analytical Chemistry
Apr 8, 2024
0
43
Cornell researchers have harnessed the power of baker's yeast to create a cost-effective and highly efficient approach for unraveling how plants synthesize medicinal compounds, and used the new method to identify key enzymes ...
Biochemistry
Oct 18, 2023
0
231
There is a global water crisis, and it is not only about the dwindling supply of clean water. Contaminated drinking water exposes hundreds of millions of people worldwide to toxins, such as bacteria, heavy metals, pesticides ...
Analytical Chemistry
Aug 10, 2023
0
18
Biopharmaceuticals are necessary, life-saving tools. But the process for making them is time-consuming and costly, particularly when it comes to the process of purification—the removal of unwanted elements like proteins, ...
Biochemistry
Sep 18, 2019
0
56
(Phys.org)—An efficient, high-volume technique for testing potential drug treatments for Alzheimer's disease uncovered an organic compound that restored motor function and longevity to fruit flies with the disease, according ...
Biochemistry
Nov 15, 2012
0
0
They're soft, biocompatible, about 7 millimeters long – and, incredibly, able to walk by themselves. Miniature "bio-bots" developed at the University of Illinois are making tracks in synthetic biology.
Engineering
Nov 15, 2012
0
0
Scientists at The Scripps Research Institute have used a powerful new chemical-screening method to find compounds that inhibit the activity of human immunodeficiency virus (HIV), the virus that causes AIDS. Unlike existing ...
Biochemistry
Jun 13, 2012
0
0
Hepatocellular carcinoma is the most common cancer to strike the liver. More than 500,000 people worldwide, concentrated in sub-Saharan Africa and Southeast Asia, are diagnosed with it yearly. Most of those afflicted die ...
Bio & Medicine
Jun 22, 2011
0
0
In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.
Biochemistry
Sep 29, 2010
0
0
